Cost-effectiveness of ceftolozane/tazobactam compared with...

Cost-effectiveness of ceftolozane/tazobactam compared with piperacillin/tazobactam as empiric therapy based on the in-vitro surveillance of bacterial isolates in the United States for the treatment of complicated urinary tract infections

Kauf, Teresa L, Prabhu, Vimalanand S., Medic, Goran, Borse, Rebekah H., Miller, Benjamin, Gaultney, Jennifer, Sen, Shuvayu S., Basu, Anirban
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
17
Language:
english
Journal:
BMC Infectious Diseases
DOI:
10.1186/s12879-017-2408-7
Date:
December, 2017
File:
PDF, 781 KB
english, 2017
Conversion to is in progress
Conversion to is failed